TLR4 c.1355_1356inv ;(p.L452Q)

Variant ID: 9-120475761-TT-AA

NM_138554.4(TLR4):c.1355_1356inv;(p.L452Q)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


A novel mutation-proof, next-generation vaccine to fight against upcoming SARS-CoV-2 variants and subvariants, designed through AI enabled approaches and tools, along with the machine learning based immune simulation: A vaccine breakthrough.

International Journal Of Biological Macromolecules
Bhattacharya, Manojit M; Alshammari, Abdulrahman A; Alharbi, Metab M; Dhama, Kuldeep K; Lee, Sang-Soo SS; Chakraborty, Chiranjib C
Publication Date: 2023-05-17

Variant appearance in text: TLR4: L452Q
PubMed Link: 37207746
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Glycosylation in SARS-CoV-2 variants: A path to infection and recovery.

Biochemical Pharmacology
Aloor, Arya A; Aradhya, Rajaguru R; Venugopal, Parvathy P; Gopalakrishnan Nair, Bipin B; Suravajhala, Renuka R
Publication Date: 2022-12

Variant appearance in text: TLR4: L452Q
PubMed Link: 36328134
Variant Present in the following documents:
  • Main text
View BVdb publication page



Innate Immune Response in SARS-CoV-2 Infection.

Microorganisms
Schiuma, Giovanna G; Beltrami, Silvia S; Bortolotti, Daria D; Rizzo, Sabrina S; Rizzo, Roberta R
Publication Date: 2022-02-23

Variant appearance in text: TLR-4: L452Q
PubMed Link: 35336077
Variant Present in the following documents:
  • Main text
  • microorganisms-10-00501.pdf
View BVdb publication page



Application of omics technology to combat the COVID-19 pandemic.

Medcomm
Yang, Jingjing J; Yan, Yunzheng Y; Zhong, Wu W
Publication Date: 2021-09

Variant appearance in text: TLR4: L452Q
PubMed Link: 34766152
Variant Present in the following documents:
  • Main text
  • MCO2-2-381.pdf
View BVdb publication page